Umberto Malapelle

Umberto Malapelle

Pansini Street 5
Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 394 publications

Editorial: Molecular characterization of thyroid lesions in the era of "next generation" techniques, volume III.

Editorial: Molecular characterization of thyroid lesions in the era of "next generation" techniques, volume III.

Journal: Frontiers in endocrinology

Published: July 02, 2026

New biomarkers for antibody-drug conjugates in lung cancer the pathologist's perspective.

New biomarkers for antibody-drug conjugates in lung cancer the pathologist's perspective.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 15, 2026

Design and analytical validation of Nexthyro 2.0, a custom next-generation sequencing panel integrating DNA mutation profiling and RNA fusion detection for routine thyroid pathology specimens.

Design and analytical validation of Nexthyro 2.0, a custom next-generation sequencing panel integrating DNA mutation profiling and RNA fusion detection for routine thyroid pathology specimens.

Journal: Virchows Archiv : an international journal of pathology

Published: June 06, 2026

Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.

Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: May 26, 2026

Hermione Exchange Educational Program: How to Integrate Multidisciplinary Approaches to Manage HR+/HER2- Metastatic Breast Cancer.

Hermione Exchange Educational Program: How to Integrate Multidisciplinary Approaches to Manage HR+/HER2- Metastatic Breast Cancer.

Journal: Cancers

Published: May 07, 2026

Beyond Blood: Liquid biopsy assays for nonplasma body fluids.

Beyond Blood: Liquid biopsy assays for nonplasma body fluids.

Journal: Surgical pathology clinics

Published: May 06, 2026

ESR1 and PIK3CA circulating tumor DNA (ctDNA) mutation status as predictive biomarkers beyond variant allele fraction (VAF) in metastatic breast cancer.

ESR1 and PIK3CA circulating tumor DNA (ctDNA) mutation status as predictive biomarkers beyond variant allele fraction (VAF) in metastatic breast cancer.

Journal: The journal of liquid biopsy

Published: May 06, 2026

PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 10, 2026

Advances in early-stage lung cancer patients: from preanalytics to molecular analysis.

Advances in early-stage lung cancer patients: from preanalytics to molecular analysis.

Journal: Critical reviews in oncology/hematology

Published: March 06, 2026

Exploring genomic analysis and methylome profiling in longitudinal series of p.G12C KRAS mutated NSCLC patients treated with sotorasib.

Exploring genomic analysis and methylome profiling in longitudinal series of p.G12C KRAS mutated NSCLC patients treated with sotorasib.

Journal: The journal of liquid biopsy

Published: March 04, 2026

The De-Centralization Perspective for Liquid Biopsy Use in Thoracic Pathology The Way to Go.

The De-Centralization Perspective for Liquid Biopsy Use in Thoracic Pathology The Way to Go.

Journal: Critical reviews in oncology/hematology

Published: February 13, 2026

Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus.

Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus.

Journal: Breast (Edinburgh, Scotland)

Published: February 12, 2026

Showing 1-12 of 394

Last Updated: 09/26/2026